Magnetic Nanoparticles PCR Enzyme‐Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia
Y Manthawornsiri, D Polpanich… - Journal of Clinical …, 2016 - Wiley Online Library
Background Magnetic nanoparticles (MNPs) have been widely used in medical diagnostic
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia.
Y Manthawornsiri, D Polpanich… - Journal of Clinical …, 2015 - europepmc.org
Background Magnetic nanoparticles (MNPs) have been widely used in medical diagnostic
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
[HTML][HTML] Magnetic Nanoparticles PCR Enzyme‐Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia
Y Manthawornsiri, D Polpanich… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Background Magnetic nanoparticles (MNPs) have been widely used in medical diagnostic
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
Magnetic Nanoparticles PCR Enzyme‐Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia
Y Manthawornsiri, D Polpanich, V Yamkamon… - Journal of Clinical …, 2016 - infona.pl
Background Magnetic nanoparticles (MNPs) have been widely used in medical diagnostic
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia
Y Manthawornsiri, D Polpanich… - Journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Magnetic nanoparticles (MNPs) have been widely used in medical diagnostic
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia
Y Manthawornsiri, D Polpanich… - Journal of Clinical …, 2016 - mahidol.elsevierpure.com
Background: Magnetic nanoparticles (MNPs) have been widely used in medical diagnostic
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia.
Y Manthawornsiri, D Polpanich… - Journal of Clinical …, 2015 - europepmc.org
Background Magnetic nanoparticles (MNPs) have been widely used in medical diagnostic
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …
research. In this work, two technologies, MNPs and polymerase chain reaction (PCR), were …